A swallowed semaglutide tablet has its own evidence
Yes, a peptide medicine can come as a swallowed tablet. The details still belong to that medicine.
A specific tablet, not a general rule
Semaglutide is a man-made version of a gut hormone involved in appetite and blood sugar. There are FDA-approved products containing it, including swallowed prescription tablets.
That's worth knowing if you've heard that peptide medicines can only be injected. It doesn't mean that any peptide placed in the mouth will work, or that every semaglutide preparation behaves the same way.
Approval belongs to a particular product and its uses. Think of a key that fits one lock. It tells us something useful about that pair, without opening every other door.
Swallowed and sublingual ask different questions
Sublingual means under the tongue. A swallowed tablet goes on to the stomach. Changing between those routes isn't just changing the wording on a page.
The approved tablet's evidence doesn't establish how much semaglutide reaches the blood from a sublingual preparation. Nor does it establish how BPC-157 or CJC-1295 behaves. Those questions need evidence of their own.
It's fair to want a simpler route. The useful follow-up is whether the exact preparation and route have been studied in people. A familiar ingredient name alone can't answer that. Product instructions also belong to the actual product, rather than to peptides as a group.
What the injection trial adds
In the STEP 1 trial, adults without diabetes had obesity, or overweight plus a weight-related health condition. Injected semaglutide led to greater average weight loss than placebo. Both groups also had a lifestyle intervention.
This was a health outcome, rather than just a measurement of drug in blood. That's why it matters. An average from a trial still doesn't predict any one person's result.
It also remains an injection finding. It can't establish that a sublingual preparation works by borrowing the ingredient's name. The comparison page puts that boundary beside the other route questions.
Approval comes with cautions
The semaglutide prescribing information lists nausea, vomiting and other digestive side effects. It also carries a boxed warning, FDA's strongest warning format, about thyroid tumors seen in rodents. Whether that happens in people is unknown.
The label rules it out for people with a personal or family history of medullary thyroid cancer, or the inherited condition MEN 2. It also rules it out after a serious allergic reaction to semaglutide or another ingredient in the product. These are product-specific cautions for a clinician to consider.
Compounded semaglutide isn't FDA-approved. FDA explains that distinction: an approved ingredient doesn't make every preparation an approved medicine.